Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Invested Capital (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Return on Invested Capital data on record, last reported at 0.08% in Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 31.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 31.0%, while the annual FY2025 figure was 0.09%, 28.0% up from the prior year.
  • Return on Invested Capital reached 0.08% in Q4 2025 per MIRM's latest filing, up from 0.15% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q4 2025 and bottomed at 2.12% in Q3 2021.
  • Average Return on Invested Capital over 5 years is 0.8%, with a median of 0.72% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: tumbled -122bps in 2021, then soared 125bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 1.93% in 2021, then skyrocketed by 59bps to 0.8% in 2022, then skyrocketed by 47bps to 0.42% in 2023, then grew by 9bps to 0.39% in 2024, then surged by 79bps to 0.08% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.08% in Q4 2025, 0.15% in Q3 2025, and 0.24% in Q2 2025.